BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lavoie B, Nausch B, Zane EA, Leonard MR, Balemba OB, Bartoo AC, Wilcox R, Nelson MT, Carey MC, Mawe GM. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil. 2012;24:e313-e324. [PMID: 22621672 DOI: 10.1111/j.1365-2982.2012.01935.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 2016;1865:245-54. [PMID: 26980625 DOI: 10.1016/j.bbcan.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
2 Matyja A, Gil K, Pasternak A, Sztefko K, Gajda M, Tomaszewski KA, Matyja M, Walocha JA, Kulig J, Thor P. Telocytes: new insight into the pathogenesis of gallstone disease. J Cell Mol Med 2013;17:734-42. [PMID: 23551596 DOI: 10.1111/jcmm.12057] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
3 Shahid RA, Wang DQ, Fee BE, McCall SJ, Romac JM, Vigna SR, Liddle RA. Endogenous elevation of plasma cholecystokinin does not prevent gallstones. Eur J Clin Invest 2015;45:237-46. [PMID: 25641074 DOI: 10.1111/eci.12400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Higashiyama H, Sumitomo H, Ozawa A, Igarashi H, Tsunekawa N, Kurohmaru M, Kanai Y. Anatomy of the Murine Hepatobiliary System: A Whole-Organ-Level Analysis Using a Transparency Method. Anat Rec (Hoboken) 2016;299:161-72. [PMID: 26559382 DOI: 10.1002/ar.23287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
5 Qu Q, Chen W, Liu X, Wang W, Hong T, Liu W, He X. Role of gallbladder-preserving surgery in the treatment of gallstone diseases in young and middle-aged patients in China: results of a 10-year prospective study. Surgery 2020;167:283-9. [PMID: 31606197 DOI: 10.1016/j.surg.2019.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cheng B, Ma J, Li G, Bai S, Xu Q, Cui X, Cheng L, Qin Y, Wang ZL. Mechanically Asymmetrical Triboelectric Nanogenerator for Self‐Powered Monitoring of In Vivo Microscale Weak Movement. Adv Energy Mater 2020;10:2000827. [DOI: 10.1002/aenm.202000827] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
7 Asai Y, Yamada T, Tsukita S, Takahashi K, Maekawa M, Honma M, Ikeda M, Murakami K, Munakata Y, Shirai Y, Kodama S, Sugisawa T, Chiba Y, Kondo Y, Kaneko K, Uno K, Sawada S, Imai J, Nakamura Y, Yamaguchi H, Tanaka K, Sasano H, Mano N, Ueno Y, Shimosegawa T, Katagiri H. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. Gastroenterology 2017;152:1521-1535.e8. [PMID: 28088462 DOI: 10.1053/j.gastro.2017.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
8 Chen L, Yu B. Telocytes and interstitial cells of Cajal in the biliary system. J Cell Mol Med. 2018;22:3323-3329. [PMID: 29700981 DOI: 10.1111/jcmm.13643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Liu M, Liu C, Chen H, Huang X, Zeng X, Zhou J, Mi S. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model. Eur J Pharmacol 2017;815:1-9. [PMID: 28993159 DOI: 10.1016/j.ejphar.2017.10.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
10 Behar J, Mawe G, Carey M. Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: cholecystitis is not caused by cystic duct obstruction. Neurogastroenterol Motil 2013;25:283-90. [DOI: 10.1111/nmo.12094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Castro-torres IG, Cárdenas-vázquez RDJ, Velázquez-gonzález C, Ventura-martínez R, De la O-arciniega M, Naranjo-rodríguez EB, Martínez-vázquez M. Future therapeutic targets for the treatment and prevention of cholesterol gallstones. European Journal of Pharmacology 2015;765:366-74. [DOI: 10.1016/j.ejphar.2015.08.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
12 Gonzalez-Escobedo G, La Perle KM, Gunn JS. Histopathological analysis of Salmonella chronic carriage in the mouse hepatopancreatobiliary system. PLoS One 2013;8:e84058. [PMID: 24349565 DOI: 10.1371/journal.pone.0084058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
13 Chen Y, Kong J, Wu S. Cholesterol gallstone disease: focusing on the role of gallbladder. Lab Invest. 2015;95:124-131. [PMID: 25502177 DOI: 10.1038/labinvest.2014.140] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bonde A, Gaitanidis A, Breen K, El Hechi M, Nederpelt C, Christensen M, Kokoroskos N, Mendoza A, Velmahos G, Sillesen M, Farhat MR, Kaafarani HMA. Identification of a new genetic variant associated with cholecystitis: A multicenter genome-wide association study. J Trauma Acute Care Surg 2020;89:173-8. [PMID: 32118827 DOI: 10.1097/TA.0000000000002647] [Reference Citation Analysis]
15 Chen Y, Weng Z, Liu Q, Shao W, Guo W, Chen C, Jiao L, Wang Q, Lu Q, Sun H, Gu A, Hu H, Jiang Z. FMO3 and its metabolite TMAO contribute to the formation of gallstones. Biochim Biophys Acta Mol Basis Dis 2019;1865:2576-85. [PMID: 31251986 DOI: 10.1016/j.bbadis.2019.06.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Hu N, Chen C, Wang J, Huang J, Yao D, Li C. Atorvastatin Ester Regulates Lipid Metabolism in Hyperlipidemia Rats via the PPAR-signaling Pathway and HMGCR Expression in the Liver. Int J Mol Sci 2021;22:11107. [PMID: 34681767 DOI: 10.3390/ijms222011107] [Reference Citation Analysis]
17 Behar J. Physiology and Pathophysiology of the Biliary Tract: The Gallbladder and Sphincter of Oddi—A Review. ISRN Physiology 2013;2013:1-15. [DOI: 10.1155/2013/837630] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
18 Yang B, Liu B, Bi P, Wu T, Wang Q, Zhang J. An integrated analysis of differential miRNA and mRNA expressions in human gallstones. Mol Biosyst 2015;11:1004-11. [PMID: 25639987 DOI: 10.1039/c4mb00741g] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
19 Woods SE, Leonard MR, Hayden JA, Brophy MB, Bernert KR, Lavoie B, Muthupalani S, Whary MT, Mawe GM, Nolan EM, Carey MC, Fox JG. Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice. Am J Physiol Gastrointest Liver Physiol 2015;308:G335-49. [PMID: 25477375 DOI: 10.1152/ajpgi.00314.2014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Hernández-Moreno D, Morales S, Camello-Almaraz C, Pozo MJ, Camello PJ. Monochloramine effects on gallbladder contractility. Clin Exp Pharmacol Physiol 2021;48:597-604. [PMID: 33352621 DOI: 10.1111/1440-1681.13453] [Reference Citation Analysis]
21 Han T, Lv Y, Wang S, Hu T, Hong H, Fu Z. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet. Lipids Health Dis 2019;18:218. [PMID: 31829191 DOI: 10.1186/s12944-019-1159-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Tharp KM, Khalifeh-Soltani A, Park HM, Yurek DA, Falcon A, Wong L, Feng R, Atabai K, Stahl A. Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis. Am J Physiol Gastrointest Liver Physiol 2016;310:G855-64. [PMID: 27033116 DOI: 10.1152/ajpgi.00316.2015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
23 Pasternak A, Gil K, Matyja A, Gajda M, Sztefko K, Walocha JA, Kulig J, Thor P. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol Motil. 2013;25:e17-e24. [PMID: 23121223 DOI: 10.1111/nmo.12037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
24 Pasternak A, Bugajska J, Szura M, Walocha JA, Matyja A, Gajda M, Sztefko K, Gil K. Biliary Polyunsaturated Fatty Acids and Telocytes in Gallstone Disease. Cell Transplant. 2017;26:125-133. [PMID: 27502173 DOI: 10.3727/096368916x692717] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Akhmedov VA, Gaus OV. Modern views on development mechanisms and tactics for treatment of patients with gallbladder disease associated with metabolic syndrome. Medicinskij alfavit 2019;2:52-6. [DOI: 10.33667/2078-5631-2019-2-13(388)-52-56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Żulpo M, Balbus J, Kuropka P, Kubica K. A model of gallbladder motility. Computers in Biology and Medicine 2018;93:139-48. [DOI: 10.1016/j.compbiomed.2017.12.018] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fu BB, Zhao JN, Wu SD, Fan Y. Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells. World J Clin Cases 2021; 9(15): 3498-3505 [PMID: 34046450 DOI: 10.12998/wjcc.v9.i15.3498] [Reference Citation Analysis]
28 Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol 2018;34:71-80. [PMID: 29283909 DOI: 10.1097/MOG.0000000000000423] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 22.7] [Reference Citation Analysis]
29 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
30 Pérez-moreno P, Riquelme I, García P, Brebi P, Roa JC. Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. JPM 2022;12:234. [DOI: 10.3390/jpm12020234] [Reference Citation Analysis]